Table 1 The relationship between TMS1 promoter methylation and clinicopathology parameter of cervical cancer
From: CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer
Characteristic | overall | present | Absent | P Value |
|---|---|---|---|---|
< 50 | 44 | 2(4.5%) | 42(95.4%) | 0.65 |
> 50 | 36 | 3(8.3%) | 33(91.6%) | Â |
Smoker | 5 | 1(20%) | 4(80%) | 0.28 |
Nonsmoker | 75 | 4(5.3%) | 71(94.6%) | Â |
Histological type SCC | 68 | 4(5.8%) | 64(94.1%) | 0.56 |
AC | 12 | 1(8.3%) | 11(91.6%) | Â |
Stage | Â | Â | Â | Â |
Ib | 46 | 1(2.2%) | 45(97.8%) | 0.10 |
IIa | 12 | 2(16.6%)IIb | 10(83.3%) | Â |
IIb | 19 | 2(10.5%) | 17(89.4%) | Â |
IIIb | 3 | - | 3(100%) | Â |